3BERGMAN A M, PINEDO H M, JONGSMA A P,et al. Decreased resistance to gemcitabine of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase[J].Biochem Pharmacol, 1999, 57:397-406.
4Rowe JM.Is there a role for intensifying induction therapy in AML[J].Best Pract Res Clin Haematol,2010,22:509-515.
5Rollig C,Thiede C,Gramatzki M,et al.A novel prognostic model in elderly patients with acute myeloid leukemia:results of 909patients entered into the prospective AML96trial[J].Blood,2010,116:971-978.
6Burnett AK,Russell NH,Hunter AE,et al.Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival[J].Blood,2013,122:1384-1394.
7Neubauer A,Maharry K,Mrozek K,et a1.Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine:a Cancer and Leukemia Group B study[J].J Clin Oncol,2010,26:4603-4609.
